Rajshekhar Chakraborty

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 56

Top Topics

Systematic Review

Venous Thromboembolism

Multiple Myeloma

Top Venues

Blood cancer journal

American journal of hematology

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Ramya Ramachandran, Darshi Shah, Catherine Luo, Veer Shah, Edward Robert Scheffer Cliff, Vaishali Sanchorawala, Suzanne Lentzsch, Rajshekhar Chakraborty
The clinical trials landscape in immunoglobulin light chain amyloidosis: a systematic review. Blood advances 8 (13) (2024)
Zimu Gong, Godsfavour Umoru, Jorge Monge, Nishi Shah, Ghulam Rehman Mohyuddin, Sabarinath Venniyil Radhakrishnan, Rajshekhar Chakraborty, Leo Rasche, Carolina D Schinke, Anita D Souza, Meera Mohan
Adverse effects and non-relapse mortality of BCMA directed T cell therapies in multiple myeloma: an FAERS database study. Blood cancer journal 14 (1) (2024)
Zimu Gong, Godsfavour Umoru, Jorge Monge, Nishi Shah, Ghulam Rehman Mohyuddin, Sabarinath Venniyil Radhakrishnan, Rajshekhar Chakraborty, Leo Rasche, Carolina D Schinke, Anita D Souza, Meera Mohan
Adverse effects and non-relapse mortality of BCMA directed T cell therapies in multiple myeloma: an FAERS database study. Blood cancer journal 14 (1) (2024)
Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Martin Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira S Mian, Luciano José Megale Costa, Douglas W Sborov, Ghulam Rehman Mohyuddin
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review. Blood cancer journal 14 (1) (2024)
Meera Mohan, Jorge Monge, Nishi Shah, Danny Luan, Mark Forsberg, Vineel Bhatlapenumarthi, Metodi Balev, Anannya Patwari, Heloise Cheruvalath, Divaya Bhutani, Sharmilan Thanendrarajan, Binod Dhakal, Maurizio Zangari, Samer Al Hadidi, Dennis Cooper, Suzanne Lentzsch, Frits Van Rhee, Anita D'Souza, Aniko Szabo, Carolina D Schinke, Rajshekhar Chakraborty
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study. Blood cancer journal 14 (1) (2024)
Charalampos Charalampous, Darshi Shah, Shaji Kumar, Rajshekhar Chakraborty
Thromboprophylaxis in multiple myeloma: a case-based review with practical guidelines. Annals of hematology (2024)
Zimu Gong, Godsfavour Umoru, Jorge Monge, Nishi Shah, Ghulam Rehman Mohyuddin, Sabarinath Venniyil Radhakrishnan, Rajshekhar Chakraborty, Leo Rasche, Carolina D Schinke, Anita D Souza, Meera Mohan
Adverse effects and non-relapse mortality of BCMA directed T cell therapies in multiple myeloma: an FAERS database study. Blood cancer journal 14 (1) (2024)
George Mellgard, Molly Gilligan, Edward R Scheffer Cliff, Divaya Bhutani, Ghulam R Mohyuddin, Andrew Eisenberger, Suzanne Lentzsch, Rajshekhar Chakraborty
Risk stratification models overestimate progression risk in contemporary patients with smoldering multiple myeloma. HemaSphere 8 (3) (2024)
Divaya Bhutani, Yusha Liu, Rajshekhar Chakraborty, Jai Radhakrishnan, Suzanne Lentzsch, Daniel Peters, Samuel M Rubinstein
Translocation (11;14) is a common cytogenetic abnormality in clonal plasma cells in monoclonal immunoglobulin deposition disease. British journal of haematology (2024)
Ramya Ramachandran, Darshi Shah, Catherine Luo, Veer Shah, Edward Robert Scheffer Cliff, Vaishali Sanchorawala, Suzanne Lentzsch, Rajshekhar Chakraborty
The clinical trials landscape in immunoglobulin light chain amyloidosis: a systematic review. Blood advances 8 (13) (2024)
Rajshekhar Chakraborty, Heloise Cheruvalath, Anannya Patwari, Aniko Szabo, Carolina D Schinke, Binod Dhakal, Suzanne Lentzsch, Anita D'Souza, Ghulam Rehman Mohyuddin, Kelley Julian, Shonali Midha, Patrick Costello, Martin F Kaiser, Melissa Ng Liet Hing, Simon James Harrison, Edward Robert Scheffer Cliff, Meera Mohan
Sustained remission following finite duration bispecific antibody therapy in patients with relapsed/refractory myeloma. Blood cancer journal 14 (1) (2024)
George S Mellgard, Divaya Bhutani, Markus Y Mapara, Mathew S Maurer, Jai Radhakrishnan, Suzanne Lentzsch, Rajshekhar Chakraborty
High-dose melphalan-autologous hematopoietic cell transplantation in systemic AL amyloidosis following daratumumab-based frontline therapy. Bone marrow transplantation 59 (8) (2024)
Ramya Ramachandran, Darshi Shah, Catherine Luo, Veer Shah, Edward Robert Scheffer Cliff, Vaishali Sanchorawala, Suzanne Lentzsch, Rajshekhar Chakraborty
The clinical trials landscape in immunoglobulin light chain amyloidosis: a systematic review. Blood advances 8 (13) (2024)
Nosakhare Paul Ilerhunmwuwa, Abul Hasan Shadali Abdul Khader, Calvin Smith, Edward Robert Scheffer Cliff, Christopher M Booth, Evevanne Hottel, Muhammad Aziz, Wade Lee-Smith, Aaron Goodman, Rajshekhar Chakraborty, Ghulam Rehman Mohyuddin
Dietary interventions in cancer: a systematic review of all randomized controlled trials. Journal of the National Cancer Institute 116 (7) (2024)
Rajshekhar Chakraborty, Saurabh Zanwar, Ute Hegenbart, Divaya Bhutani, Morie A Gertz, Angela Dispenzieri, Shaji K Kumar, Anita D'Souza, Anannya Patwari, Andrew J Cowan, Gui Zhen Chen, Paolo Milani, Giovanni Palladini, Vaishali Sanchorawala, Geethika Bodanapu, Stefan Schönland, Suzanne Lentzsch, Eli Muchtar
Prognostic impact of cytogenetic abnormalities by FISH in AL amyloidosis with daratumumab-based frontline therapy. Blood (2024)
Nosakhare Paul Ilerhunmwuwa, Abul Hasan Shadali Abdul Khader, Calvin Smith, Edward Robert Scheffer Cliff, Christopher M Booth, Evevanne Hottel, Muhammad Aziz, Wade Lee-Smith, Aaron Goodman, Rajshekhar Chakraborty, Ghulam Rehman Mohyuddin
Dietary interventions in cancer: a systematic review of all randomized controlled trials. Journal of the National Cancer Institute 116 (7) (2024)
Meera Mohan, Jorge Monge, Nishi Shah, Danny Luan, Mark Forsberg, Vineel Bhatlapenumarthi, Metodi Balev, Anannya Patwari, Heloise Cheruvalath, Divaya Bhutani, Sharmilan Thanendrarajan, Binod Dhakal, Maurizio Zangari, Samer Al Hadidi, Dennis Cooper, Suzanne Lentzsch, Frits Van Rhee, Anita D'Souza, Aniko Szabo, Carolina D Schinke, Rajshekhar Chakraborty
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study. Blood cancer journal 14 (1) (2024)
George S Mellgard, Divaya Bhutani, Markus Y Mapara, Mathew S Maurer, Jai Radhakrishnan, Suzanne Lentzsch, Rajshekhar Chakraborty
High-dose melphalan-autologous hematopoietic cell transplantation in systemic AL amyloidosis following daratumumab-based frontline therapy. Bone marrow transplantation (2024)
Meera Mohan, Jorge Monge, Nishi Shah, Danny Luan, Mark Forsberg, Vineel Bhatlapenumarthi, Metodi Balev, Anannya Patwari, Heloise Cheruvalath, Divaya Bhutani, Sharmilan Thanendrarajan, Binod Dhakal, Maurizio Zangari, Samer Al Hadidi, Dennis Cooper, Suzanne Lentzsch, Frits Van Rhee, Anita D'Souza, Aniko Szabo, Carolina D Schinke, Rajshekhar Chakraborty
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study. Blood cancer journal 14 (1) (2024)
Abdul-Hamid Bazarbachi, Divaya Bhutani, Jai Radhakrishnan, Markus Mapara, Mathew S Maurer, Suzanne Lentzsch, Rajshekhar Chakraborty
Timing and outcomes of second-line therapy in the era of daratumumab-based frontline therapy in AL amyloidosis. American journal of hematology (2024)
Apoorva Kakkilaya, Aaron Trando, Edward Robert Scheffer Cliff, Hira Mian, Samer Al Hadidi, Muhammad Aziz, Aaron M Goodman, Ah-Reum Jeong, Wade L Smith, Amar H Kelkar, David A Russler-Germain, Nikita Mehra, Rajshekhar Chakraborty, Morie A Gertz, Ghulam Rehman Mohyuddin
Evaluating early intervention in smoldering myeloma clinical trials: a systematic review. The oncologist (2024)
Rajshekhar Chakraborty, Hira S Mian
Quadruplets in newly diagnosed transplant-ineligible multiple myeloma. American journal of hematology (2024)
Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Martin Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira S Mian, Luciano José Megale Costa, Douglas W Sborov, Ghulam Rehman Mohyuddin
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review. Blood cancer journal 14 (1) (2024)
Ramya Ramachandran, Darshi Shah, Catherine Luo, Veer Shah, Edward Robert Scheffer Cliff, Vaishali Sanchorawala, Suzanne Lentzsch, Rajshekhar Chakraborty
The Clinical Trials Landscape in Immunoglobulin Light Chain Amyloidosis: A Systematic Review. Blood advances (2024)
Rajshekhar Chakraborty, Heloise Cheruvalath, Anannya Patwari, Aniko Szabo, Carolina D Schinke, Binod Dhakal, Suzanne Lentzsch, Anita D'Souza, Ghulam Rehman Mohyuddin, Kelley Julian, Shonali Midha, Patrick Costello, Martin F Kaiser, Melissa Ng Liet Hing, Simon James Harrison, Edward Robert Scheffer Cliff, Meera Mohan
Sustained remission following finite duration bispecific antibody therapy in patients with relapsed/refractory myeloma. Blood cancer journal 14 (1) (2024)
Meera Mohan, Jorge Monge, Nishi Shah, Danny Luan, Mark Forsberg, Vineel Bhatlapenumarthi, Metodi Balev, Anannya Patwari, Heloise Cheruvalath, Divaya Bhutani, Sharmilan Thanendrarajan, Binod Dhakal, Maurizio Zangari, Samer Al Hadidi, Dennis Cooper, Suzanne Lentzsch, Frits Van Rhee, Anita D'Souza, Aniko Szabo, Carolina D Schinke, Rajshekhar Chakraborty
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study. Blood cancer journal 14 (1) (2024)
Zimu Gong, Godsfavour Umoru, Jorge Monge, Nishi Shah, Ghulam Rehman Mohyuddin, Sabarinath Venniyil Radhakrishnan, Rajshekhar Chakraborty, Leo Rasche, Carolina D Schinke, Anita D Souza, Meera Mohan
Adverse effects and non-relapse mortality of BCMA directed T cell therapies in multiple myeloma: an FAERS database study. Blood cancer journal 14 (1) (2024)
Rajshekhar Chakraborty, Heloise Cheruvalath, Anannya Patwari, Aniko Szabo, Carolina D Schinke, Binod Dhakal, Suzanne Lentzsch, Anita D'Souza, Ghulam Rehman Mohyuddin, Kelley Julian, Shonali Midha, Patrick Costello, Martin F Kaiser, Melissa Ng Liet Hing, Simon James Harrison, Edward Robert Scheffer Cliff, Meera Mohan
Sustained remission following finite duration bispecific antibody therapy in patients with relapsed/refractory myeloma. Blood cancer journal 14 (1) (2024)
Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Martin Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira S Mian, Luciano José Megale Costa, Douglas W Sborov, Ghulam Rehman Mohyuddin
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review. Blood cancer journal 14 (1) (2024)
Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Martin Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira S Mian, Luciano José Megale Costa, Douglas W Sborov, Ghulam Rehman Mohyuddin
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review. Blood cancer journal 14 (1) (2024)
George Mellgard, Molly Gilligan, Edward R Scheffer Cliff, Divaya Bhutani, Ghulam R Mohyuddin, Andrew Eisenberger, Suzanne Lentzsch, Rajshekhar Chakraborty
Risk stratification models overestimate progression risk in contemporary patients with smoldering multiple myeloma. HemaSphere 8 (3) (2024)
Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Martin Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira S Mian, Luciano José Megale Costa, Douglas W Sborov, Ghulam Rehman Mohyuddin
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review. Blood cancer journal 14 (1) (2024)
Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Martin Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira S Mian, Luciano José Megale Costa, Douglas W Sborov, Ghulam Rehman Mohyuddin
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review. Blood cancer journal 14 (1) (2024)
Rajshekhar Chakraborty, Samer Al Hadidi
Intent Matters: Real-World Applicability of ide-cel Usage in the United States. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Rajshekhar Chakraborty, Cara A Rosenbaum, Gurbakhash Kaur, Divaya Bhutani, Jai Radhakrishnan, Markus Y Mapara, Mathew Maurer, Suzanne Lentzsch
First report of outcomes in patients with stage IIIb AL amyloidosis treated with Dara-VCD front-line therapy. British journal of haematology (2023)
Rajshekhar Chakraborty, Divaya Bhutani, Markus Mapara, Ran Reshef, Mathew S Maurer, Jai Radhakrishnan, Suzanne Lentzsch
Reduced early mortality with Daratumumab-based frontline therapy in AL amyloidosis: A retrospective cohort study. American journal of hematology 99 (3) (2023)
Rajshekhar Chakraborty, Divaya Bhutani, Markus Mapara, Ran Reshef, Mathew S Maurer, Jai Radhakrishnan, Suzanne Lentzsch
Reduced early mortality with Daratumumab-based frontline therapy in AL amyloidosis: A retrospective cohort study. American journal of hematology 99 (3) (2023)
Rajshekhar Chakraborty, Divaya Bhutani, Markus Mapara, Ran Reshef, Mathew S Maurer, Jai Radhakrishnan, Suzanne Lentzsch
Reduced early mortality with Daratumumab-based frontline therapy in AL amyloidosis: A retrospective cohort study. American journal of hematology (2023)
Rajshekhar Chakraborty, Divaya Bhutani, Markus Mapara, Ran Reshef, Mathew S Maurer, Jai Radhakrishnan, Suzanne Lentzsch
Reduced early mortality with Daratumumab-based frontline therapy in AL amyloidosis: A retrospective cohort study. American journal of hematology 99 (3) (2023)
Rajshekhar Chakraborty, Samer Al Hadidi, Edward Robert Scheffer Cliff, Ghulam Rehman Mohyuddin
Is aggressive treatment of smoldering myeloma the path to curing myeloma? Blood advances (2023)
Shirong Li, Jing Fu, Christopher J Walker, Jun Yang, Divaya Bhutani, Rajshekhar Chakraborty, Niha Mamillapalli, Markus Y Mapara, Yosef Landesman, Suzanne Lentzsch
Dual targeting of protein translation and nuclear protein export results in enhanced anti-myeloma effects. Blood advances (2023)
Rajshekhar Chakraborty, Divaya Bhutani, Mathew S Maurer, Meera Mohan, Suzanne Lentzsch, Anita D Souza
Safety and efficacy of teclistamab in systemic immunoglobulin light chain amyloidosis. Blood cancer journal 13 (1) (2023)
Rajshekhar Chakraborty, Jens Hillengass, Suzanne Lentzsch
How do we image patients with multiple myeloma and precursor states? British journal of haematology (2023)
Rajshekhar Chakraborty, Suzanne Lentzch
Circulating Tumor Cell Burden as a Component of Staging in Multiple Myeloma: Ready for Prime Time? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (27) (2022)
Rajshekhar Chakraborty, Rabbia Siddiqi, Gloria Willson, Samiksha Gupta, Noureen Asghar, Muhammad Husnain, Mohammed A Aljama, Tapas Ranjan Behera, Faiz Anwer, Aurore Perrot, Irbaz B Riaz
Impact of autologous transplantation on survival in patients with newly diagnosed multiple myeloma who have high-risk cytogenetics: A meta-analysis of randomized controlled trials. Cancer 128 (12) (2022)
Rajshekhar Chakraborty, Lisa A Rybicki, Wei Wei, Jason Valent, Beth M Faiman, Christy Samaras, Faiz Anwar, Alok A Khorana
Abnormal Metaphase Cytogenetics Predicts Venous Thromboembolism in Myeloma: Derivation and Validation of the PRISM Score. Blood (2022)
Rajshekhar Chakraborty, Divaya Bhutani, Suzanne Lentzsch
How do we manage t(11;14) plasma cell disorders with venetoclax? British journal of haematology 199 (1) (2022)
Rajshekhar Chakraborty, Madeleine Hopson, Divaya Bhutani, George Vlad, Mathew S Maurer, Jan M Griffin, Markus Y Mapara, Jai Radhakrishnan, Suzanne Lentzsch
Impact of bone marrow minimal residual disease status on quality of organ response in systemic AL amyloidosis. American journal of hematology 97 (7) (2022)
Rajshekhar Chakraborty, Lisa Rybicki, Megan O Nakashima, Robert M Dean, Beth M Faiman, Christy J Samaras, Nathaniel Rosko, Hayley Dysert, Jason Valent, Faiz Anwer
Characterisation and prognostic impact of immunoparesis in relapsed multiple myeloma. British journal of haematology 189 (6) (2020)
Rajshekhar Chakraborty, Navneet S Majhail
Treatment and disease-related complications in multiple myeloma: Implications for survivorship. American journal of hematology 95 (6) (2020)
Rajshekhar Chakraborty, Fabio Efficace
Importance of quality of life in early phase clinical trials: A case study of selinexor in multiple myeloma. British journal of haematology 189 (3) (2020)
Rajshekhar Chakraborty, Irbaz Bin Riaz, Saad Ullah Malik, Naimisha Marneni, Alex Mejia Garcia, Faiz Anwer, Alok A Khorana, S Vincent Rajkumar, Shaji K Kumar, M Hassan Murad, Zhen Wang, Safi U Khan, Navneet S Majhail
Venous thromboembolism risk with contemporary lenalidomide-based regimens despite thromboprophylaxis in multiple myeloma: A systematic review and meta-analysis. Cancer 126 (8) (2020)
Binod Dhakal, Anita D'Souza, Natalie Callander, Saurabh Chhabra, Raphael Fraser, Omar Davila, Kenneth Anderson, Amer Assal, Sherif M Badawy, Jesus Berdeja, Jan Cerny, Raymond L Comenzo, Rajshekhar Chakraborty, Robert Peter Gale, Rammurti Kamble, Mohamed A Kharfan-Dabaja, Maxwell Krem, Siddhartha Ganguly, Murali Janakiram, Ankit Kansagra, Reinhold Munker, Hemant Murthy, Sagar S Patel, Shaji K Kumar, Nina Shah, Muzaffar Qazilbash, Parameswaran Hari
Novel prognostic scoring system for autologous hematopoietic cell transplantation in multiple myeloma. British journal of haematology 191 (3) (2020)
Rajshekhar Chakraborty, Suzanne Lentzsch
Prognostic impact of t(11;14) in multiple myeloma: Black and white or shades of gray? Cancer 127 (1) (2020)
Rajshekhar Chakraborty, Hien D Liu, Lisa Rybicki, Jacqulyn Tomer, Jack Khouri, Robert M Dean, Beth M Faiman, Matt Kalaycio, Christy J Samaras, Navneet S Majhail, Jason Valent
Progression with clinical features is associated with worse subsequent survival in multiple myeloma. American journal of hematology 94 (4) (2019)
Rajshekhar Chakraborty, Eli Muchtar, Shaji K Kumar, Francis K Buadi, David Dingli, Angela Dispenzieri, Suzanne R Hayman, William J Hogan, Prashant Kapoor, Martha Q Lacy, Nelson Leung, Rahma Warsame, Taxiarchis Kourelis, Wilson I Gonsalves, Morie A Gertz
Impact of duration of induction therapy on survival in newly diagnosed multiple myeloma patients undergoing upfront autologous stem cell transplantation. British journal of haematology 182 (1) (2018)